Precipitated Calcium Carbonate may be available in the countries listed below.
Precipitated Calcium Carbonate (JAN) is known as Calcium Carbonate in the US.
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
Isosorbide mononitraat Mylan may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Isosorbide mononitraat Mylan in the following countries:
International Drug Name Search
Maxit may be available in the countries listed below.
Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Maxit in the following countries:
International Drug Name Search
Ambasept may be available in the countries listed below.
Ambazone is reported as an ingredient of Ambasept in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, DDAVP (desmopressin systemic) is a member of the drug class antidiuretic hormones and is used to treat Diabetes Insipidus, Hemophilia A, Primary Nocturnal Enuresis and von Willebrand's Disease.
US matches:
UK matches:
Desmopressin is reported as an ingredient of DDAVP in the following countries:
Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of DDAVP in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
In some countries, this medicine may only be approved for veterinary use.
Butorphanol tartrate (a derivative of Butorphanol) is reported as an ingredient of Torbugesic in the following countries:
International Drug Name Search
Anastrozol Teva may be available in the countries listed below.
Anastrozole is reported as an ingredient of Anastrozol Teva in the following countries:
International Drug Name Search
Timolol T may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Timolol T in the following countries:
International Drug Name Search
Giafen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Guaifenesin is reported as an ingredient of Giafen in the following countries:
International Drug Name Search
Gynostatin may be available in the countries listed below.
Nystatin is reported as an ingredient of Gynostatin in the following countries:
International Drug Name Search
Ginedermofix Vaginal may be available in the countries listed below.
Sertaconazole nitrate (a derivative of Sertaconazole) is reported as an ingredient of Ginedermofix Vaginal in the following countries:
International Drug Name Search
Wipeout may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Deltamethrin is reported as an ingredient of Wipeout in the following countries:
International Drug Name Search
Limonata may be available in the countries listed below.
Magnesium Carbonate is reported as an ingredient of Limonata in the following countries:
International Drug Name Search
Gluconate de Calcium Lavoisier may be available in the countries listed below.
Calcium Glucoheptonate is reported as an ingredient of Gluconate de Calcium Lavoisier in the following countries:
Calcium Gluconate is reported as an ingredient of Gluconate de Calcium Lavoisier in the following countries:
International Drug Name Search
Goserelin Acetate may be available in the countries listed below.
Goserelin Acetate (BANM, JAN) is known as Goserelin in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| JAN | Japanese Accepted Name |
Dodorest may be available in the countries listed below.
Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Dodorest in the following countries:
International Drug Name Search
Benemide may be available in the countries listed below.
Probenecid is reported as an ingredient of Benemide in the following countries:
International Drug Name Search
Insulin Actrapid may be available in the countries listed below.
Insulin Injection, Soluble human (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin Actrapid in the following countries:
Insulin Injection, Soluble porcine or bovine (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin Actrapid in the following countries:
International Drug Name Search
Cefazolina Biocrom may be available in the countries listed below.
Cefazolin is reported as an ingredient of Cefazolina Biocrom in the following countries:
International Drug Name Search
In the US, Lomotil (atropine/diphenoxylate systemic) is a member of the drug class antidiarrheals and is used to treat Diarrhea.
US matches:
UK matches:
Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Lomotil in the following countries:
Diphenoxylate hydrochloride (a derivative of Diphenoxylate) is reported as an ingredient of Lomotil in the following countries:
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Lomotil in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Chuben may be available in the countries listed below.
Albendazole is reported as an ingredient of Chuben in the following countries:
International Drug Name Search
Follistim AQ is a brand name of follicle stimulating hormone, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Follistim AQ available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Follistim AQ. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Saltos may be available in the countries listed below.
Salbutamol is reported as an ingredient of Saltos in the following countries:
International Drug Name Search
Nortan may be available in the countries listed below.
Atenolol is reported as an ingredient of Nortan in the following countries:
International Drug Name Search
Raxide may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Raxide in the following countries:
International Drug Name Search
Spironolactone Altizide Biogaran may be available in the countries listed below.
Altizide is reported as an ingredient of Spironolactone Altizide Biogaran in the following countries:
Spironolactone is reported as an ingredient of Spironolactone Altizide Biogaran in the following countries:
International Drug Name Search
Fluconazol-GRY may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazol-GRY in the following countries:
International Drug Name Search
Opipramol-neuraxpharm may be available in the countries listed below.
Opipramol dihydrochloride (a derivative of Opipramol) is reported as an ingredient of Opipramol-neuraxpharm in the following countries:
International Drug Name Search
Inderalici may be available in the countries listed below.
Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Inderalici in the following countries:
International Drug Name Search
Cefotim may be available in the countries listed below.
Cefotaxime is reported as an ingredient of Cefotim in the following countries:
International Drug Name Search
Generic Name: brompheniramine/carbetapentane/phenylephrine (brome fen IR a meen, kar be ta PEN tane, fen il EF rin)
Brand names: BetaTan, Pulmari, VazoTan, Seradex, V-Cof, Trexbrom
Carbetapentane is a cough suppressant.
Brompheniramine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in the body. Histamine can produce allergy symptoms such as sneezing, runny nose, and watery eyes.
Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).
The combination of brompheniramine, carbetapentane and phenylephrine is used to treat cough and nasal congestion associated with allergies or the common cold.
Brompheniramine, carbetapentane and phenylephrine may also be used for purposes other than those listed in this medication guide.
Avoid using other medicines that make you sleepy (such as cold medicine, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, carbetapentane, and phenylephrine.
Before taking this medication, tell your doctor if you are allergic to any drugs, or if you have:
a history of head injury or seizure disorder;
sleep apnea (periods of not breathing during sleep);
thyroid problems;
asthma, emphysema, or chronic obstructive pulmonary disease (COPD);
gallbladder disease;
Addison's disease;
diabetes;
glaucoma;
an ulcer or an obstruction in the stomach;
bladder problems or difficulty urinating;
high blood pressure, irregular heartbeats, or any type of heart disease;
If you have any of these conditions, you may not be able to use brompheniramine, carbetapentane, and phenylephrine, or you may need a dosage adjustment or special tests during treatment.
Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.
Call your doctor if your symptoms do not improve, if they get worse, or if you develop a fever.
See also: Brompheniramine/carbetapentane/phenylephrine dosage (in more detail)
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.
Symptoms of a brompheniramine, carbetapentane and phenylephrine overdose may include dry mouth, large pupils, warmth or tingling under the skin, nausea, vomiting, restless feeling, or hallucinations.
Avoid using other medicines that make you sleepy (such as cold medicine, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, carbetapentane, and phenylephrine.
Less serious side effects are more likely to occur with this medication, such as:
dryness of the eyes, nose, or mouth;
drowsiness or dizziness;
blurred vision;
difficulty urinating; or
excitation (in children).
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Allergic Rhinitis:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL or brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension: 5 to 10 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
Usual Adult Dose for Cold Symptoms:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL or brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension: 5 to 10 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
Usual Adult Dose for Cough and Nasal Congestion:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL or brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension: 5 to 10 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
Usual Pediatric Dose for Allergic Rhinitis:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 2.5 to 5 mL orally every 12 hours.
2 yrs to 5 yrs: 1.25 to 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 5 mL orally every 12 hours.
2 yrs to 5 yrs: 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
6 yrs to 11 yrs: 2.5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
Usual Pediatric Dose for Cold Symptoms:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 2.5 to 5 mL orally every 12 hours.
2 yrs to 5 yrs: 1.25 to 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 5 mL orally every 12 hours.
2 yrs to 5 yrs: 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
6 yrs to 11 yrs: 2.5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
Usual Pediatric Dose for Cough and Nasal Congestion:
brompheniramine/carbetapentane/phenylephrine 4 mg-30 mg-7.5 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 2.5 to 5 mL orally every 12 hours.
2 yrs to 5 yrs: 1.25 to 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-25 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 to 10 mL orally every 12 hours.
6 yrs to 11 yrs: 5 mL orally every 12 hours.
2 yrs to 5 yrs: 2.5 mL orally every 12 hours.
brompheniramine/carbetapentane/phenylephrine 6 mg-30 mg-10 mg/5 mL oral suspension:
12 yrs or older: 5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
6 yrs to 11 yrs: 2.5 mL orally every 6 hours. Not to exceed 4 doses in 24 hours.
There may be other drugs not listed that can affect brompheniramine, carbetapentane, and phenylephrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: brompheniramine/carbetapentane/phenylephrine side effects (in more detail)
Tilhasan may be available in the countries listed below.
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Tilhasan in the following countries:
International Drug Name Search
Clozapine Mylan may be available in the countries listed below.
Clozapine is reported as an ingredient of Clozapine Mylan in the following countries:
International Drug Name Search
Kanrenol may be available in the countries listed below.
Potassium Canrenoate is reported as an ingredient of Kanrenol in the following countries:
International Drug Name Search
Dacarbazine DBL may be available in the countries listed below.
Dacarbazine is reported as an ingredient of Dacarbazine DBL in the following countries:
International Drug Name Search
Treatment of the symptoms of irritable bowel syndrome. It may also be used for other conditions as determined by your doctor.
Dicyclomine Syrup is an anticholinergic. It works by blocking a chemical in the smooth muscle of the stomach and intestines causing them to relax, which reduces cramping.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dicyclomine Syrup. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dicyclomine Syrup. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dicyclomine Syrup may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dicyclomine Syrup as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dicyclomine Syrup.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Blurred vision; constipation; decreased sweating; difficulty sleeping; dizziness; drowsiness; dry mouth; headache; lightheadedness; loss of taste; nausea; nervousness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); agitation; confusion; diarrhea; difficulty focusing your eyes; difficulty moving; difficulty speaking; difficulty urinating; disorientation; exaggerated sense of well-being; fainting; hallucinations; pounding in the chest; rapid heartbeat; short-term memory loss; unusual weakness; vomiting.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch .
See also: Dicyclomine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include convulsions (seizures); difficulty breathing; dilated pupils; disorientation; excessive thirst; flushed, hot, dry skin; hallucinations or unusual behavior; muscle weakness; nausea; rapid heartbeat and breathing; restlessness; severe dizziness or drowsiness; severe dry mouth; vomiting.
Store at room temperature, below 86 degrees F (30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dicyclomine Syrup out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dicyclomine Syrup. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Cetoros may be available in the countries listed below.
Piracetam is reported as an ingredient of Cetoros in the following countries:
International Drug Name Search
Cuterpès may be available in the countries listed below.
Ibacitabine is reported as an ingredient of Cuterpès in the following countries:
International Drug Name Search
In the US, Isosorbide Mononitrate (isosorbide mononitrate systemic) is a member of the drug class antianginal agents and is used to treat Angina Pectoris Prophylaxis, Esophageal Spasm and Heart Failure.
US matches:
UK matches:
Isosorbide Mononitrate (BAN, JAN, USAN) is known as Isosorbide Mononitrate in the US.
Isosorbide is reported as an ingredient of Isosorbide Mononitrate in the following countries:
International Drug Name Search
Glossary
| BAN | British Approved Name |
| JAN | Japanese Accepted Name |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Miotens may be available in the countries listed below.
Thiocolchicoside is reported as an ingredient of Miotens in the following countries:
International Drug Name Search
Tradil may be available in the countries listed below.
Dexibuprofen is reported as an ingredient of Tradil in the following countries:
International Drug Name Search
Toricam Gel may be available in the countries listed below.
Piroxicam is reported as an ingredient of Toricam Gel in the following countries:
International Drug Name Search
Sylvie may be available in the countries listed below.
Ethinylestradiol is reported as an ingredient of Sylvie in the following countries:
Gestodene is reported as an ingredient of Sylvie in the following countries:
International Drug Name Search
Ichtholan may be available in the countries listed below.
Ichthammol is reported as an ingredient of Ichtholan in the following countries:
Ichthammol decolorized (a derivative of Ichthammol) is reported as an ingredient of Ichtholan in the following countries:
International Drug Name Search
Oxycyclin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxycyclin in the following countries:
International Drug Name Search
Ibuprofeno All Pro may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibuprofeno All Pro in the following countries:
International Drug Name Search
Nitroglycerinum may be available in the countries listed below.
Nitroglycerin is reported as an ingredient of Nitroglycerinum in the following countries:
International Drug Name Search
Burgerstein Beta-Carotin may be available in the countries listed below.
Betacarotene is reported as an ingredient of Burgerstein Beta-Carotin in the following countries:
International Drug Name Search
Rec.INN
D04AA22,R06AD09
0000482-15-5
C16-H19-N3-S
285
Antiallergic agent
Histamine, H₁-receptor antagonist
10H-Pyrido[3,2-b][1,4]benzothiazine-10-ethanamine, N,N,α-trimethyl-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Irritos may be available in the countries listed below.
Dextromethorphan is reported as an ingredient of Irritos in the following countries:
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Irritos in the following countries:
Phenylpropanolamine hydrochloride (a derivative of Phenylpropanolamine) is reported as an ingredient of Irritos in the following countries:
International Drug Name Search
In the US, Pulmicort Turbuhaler (budesonide systemic) is a member of the drug class inhaled corticosteroids and is used to treat Asthma, Maintenance.
US matches:
Budesonide is reported as an ingredient of Pulmicort Turbuhaler in the following countries:
International Drug Name Search
Furomex may be available in the countries listed below.
Furosemide is reported as an ingredient of Furomex in the following countries:
International Drug Name Search
Estradiol Apotex may be available in the countries listed below.
Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estradiol Apotex in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
0001317-38-0
Cu-O
79
Copper(II) oxide (IUPAC)
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
broe-moe-KRIP-teen
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antiparkinsonian
Pharmacologic Class: Dopamine Agonist
Bromocriptine belongs to the group of medicines known as ergot alkaloids. Bromocriptine blocks release of a hormone called prolactin from the pituitary gland. Prolactin affects the menstrual cycle and milk production. Bromocriptine is used to treat certain menstrual problems or to stop milk production in some women or men who have abnormal milk leakage. It is also used to treat infertility in both men and women that occurs because the body made too much prolactin.
Bromocriptine is also used to treat some people who have Parkinson's disease. It works by stimulating certain parts of the brain and nervous system that are involved in this disease.
Bromocriptine is also used to treat acromegaly (overproduction of growth hormone) and pituitary prolactinomas (tumors of the pituitary gland).
Bromocriptine is also used together with proper diet and exercise to treat high blood sugar levels in patients with type 2 diabetes.
Bromocriptine may also be used for other conditions as determined by your doctor.
bromocriptine is available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, bromocriptine is used in certain patients with the following medical conditions:
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bromocriptine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to bromocriptine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of bromocriptine in the pediatric population. Safety and efficacy have not been established.
bromocriptine has been tested in a limited number of teenagers 15 years of age and older. In effective doses, the medicine has not been shown to cause different side effects or problems than it does in adults. Appropriate studies have not been done in teenagers younger than 15 years of age, and there is no specific information comparing use of bromocriptine in these teenagers with use in other age groups.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bromocriptine in the elderly.
Confusion, hallucinations, or uncontrolled body movements may be more likely to occur in elderly patients, who are usually more sensitive than younger adults to the effects of bromocriptine.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
Studies suggest that this medication may alter milk production or composition. If an alternative to this medication is not prescribed, you should monitor the infant for side effects and adequate milk intake.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking bromocriptine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using bromocriptine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using bromocriptine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of bromocriptine. Make sure you tell your doctor if you have any other medical problems, especially:
bromocriptine comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.
Follow carefully the special meal plan your doctor gave you. This is the most important part of controlling your condition, and is necessary if the medicine is to work properly. Also, exercise regularly and test for sugar in your blood or urine as directed.
If bromocriptine upsets your stomach, it may be taken with meals or milk. Also, taking the dose at bedtime may help to lessen nausea if it occurs. If stomach upset continues, check with your doctor. Your doctor may recommend that you take the first doses vaginally.
The dose of bromocriptine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of bromocriptine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of bromocriptine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is important that your doctor check your progress at regular visits to make sure that bromocriptine is working properly. Blood tests may be needed to check for unwanted effects.
It is very important to follow carefully any instructions from your health care team about:
bromocriptine may cause some people to become drowsy, dizzy, or less alert than they are normally. Make sure you know how you react to bromocriptine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.
Dizziness, lightheadedness, or fainting may occur, especially when you get up from a lying or sitting position suddenly. These symptoms are more likely to occur when you begin taking bromocriptine, or when the dose is increased.
Too much bromocriptine can cause low blood sugar (hypoglycemia) when it is used under certain conditions. Symptoms of low blood sugar must be treated before they lead to unconsciousness (passing out). Different people may feel different symptoms of low blood sugar. It is important that you learn which symptoms of low blood sugar you usually have so that you can treat it quickly and call someone on your health care team right away when you need advice.
Symptoms of hypoglycemia (low blood sugar) include anxiety; behavior change similar to being drunk; blurred vision; cold sweats; confusion; cool, pale skin; difficulty in thinking; drowsiness; excessive hunger; fast heartbeat; headache (continuing); nausea; nervousness; nightmares; restless sleep; shakiness; slurred speech; or unusual tiredness or weakness.
If symptoms of low blood sugar occur, eat glucose tablets or gel, corn syrup, honey, or sugar cubes; or drink fruit juice, non-diet soft drink, or sugar dissolved in water. Also, check your blood for low blood sugar. Glucagon is used in emergency situations when severe symptoms such as seizures (convulsions) or unconsciousness occur. Have a glucagon kit available, along with a syringe or needle, and know how to use it. Members of your household also should know how to use it.
High blood sugar may occur if you do not exercise as much as usual, have a fever or infection, do not take enough or skip a dose of your diabetes medicine, or overeat or do not follow your meal plan.
If symptoms of high blood sugar occur, check your sugar level and then call your doctor for instructions.
Dizziness is more likely to occur after the first dose of bromocriptine. Taking the first dose at bedtime or when you are able to lie down may lessen problems. It may also be helpful if you get up slowly from a lying or sitting position. Your doctor may also recommend that you take the first dose vaginally.
Bromocriptine may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute. However, if dry mouth continues for more than 2 weeks, check with your medical doctor or dentist. Continuing dryness of the mouth may increase the chance of dental disease, including tooth decay, gum disease, and fungus infections.
It may take several weeks for bromocriptine to work. Do not stop taking bromocriptine or reduce the amount you are taking without first checking with your doctor.
Drinking alcohol while you are taking bromocriptine may cause you to have a certain reaction. Avoid alcoholic beverages until you have discussed this with your doctor. Some of the symptoms you may have if you drink any alcohol while you are taking bromocriptine are blurred vision, chest pain, confusion, fast or pounding heartbeat, flushing or redness of the face, nausea, severe weakness, sweating, throbbing headache, or vomiting.
For females who are able to bear children and who are taking bromocriptine for menstrual or infertility problems, to stop milk production, or to treat acromegaly or pituitary tumors:
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Some serious side effects have occurred during the use of bromocriptine to stop milk flow after pregnancy or abortion. These side effects have included strokes, seizures (convulsions), and heart attacks. Some deaths have also occurred. You should discuss with your doctor the good that bromocriptine will do as well as the risks of using it.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Some side effects may be more likely to occur in patients who are taking bromocriptine for Parkinson's disease, acromegaly, or pituitary tumors since they may be taking larger doses.
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: bromocriptine side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
